-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the new crown vaccine developed and produced by China arrived in African countries such as Zimbabwe, Senegal and Equatorial Guinea, and was praised by many African leaders.
When some developed countries have purchased a large number of new crown vaccines and when the demand for vaccines in underdeveloped countries and regions cannot be responded in time, China has taken practical actions to fulfill its commitments to make vaccines a global public product and promote the construction of a human health and health community.
United Nations data shows that 10 countries control 75% of the world's new crown vaccine.
Up to now, China has provided vaccine assistance to African countries such as Zimbabwe, Sierra Leone, and Equatorial Guinea.
The Kenyan "People's Daily" recently published a review article criticizing some countries for politicizing the epidemic, rejecting science, inciting prejudice, advocating false information, using political power to hoard vaccines, and turning a blind eye to the needs of underdeveloped countries and regions.
At present, China has donated vaccines to 53 developing countries that have requested it, has exported vaccines to 22 countries, and has provided 10 million doses of vaccines for the new crown pneumonia vaccine implementation plan to meet the urgent needs of developing countries.
Coronavirus disease